Nomvec AS

What Nomvec AS does

Nomvec AS is a Norwegian non-profit company that develops, operates, and maintains the Norwegian Medicines Verification System (NoMVS), the national e-verification database for pharmaceutical products in Norway. Established by the pharmaceutical industry to comply with EU Regulation 2016/161 (Falsified Medicines Directive), Nomvec is wholly owned by Legemiddelindustrien (LMI) and operates under agreement with the Norwegian Medicines Verification Organisation (NoMVO), which represents all supply chain stakeholders including MAHs, pharmacies, wholesalers, hospitals, and parallel importers. The company serves as the legal entity responsible for contracting with Marketing Authorization Holders (MAHs), onboarding them to the EU HUB, and verifying the legitimacy of pharmacies, wholesalers, and hospital departments requiring NoMVS access.

The core technology, NoMVS, is built on infrastructure supplied by Arvato Systems (used by 16 countries as NMVS provider) and verifies 2D matrix codes on prescription medicine packages, cross-referencing unique serial numbers, GTIN product codes, batch numbers, and expiry dates against the national database connected to the pan-European EU HUB. The system processes approximately 60 million package verifications annually in Norway and operates within the broader EMVS network of 29 EU/EEA countries handling 30 million daily transactions. Supporting products include the Alert Management System (classifying L1-L5 severity events), automated alert distribution three times weekly, a Troubleshooting Matrix for error resolution, and a SPOC (Single Point of Contact) first-line support function.

Nomvec's revenue model is a hybrid fee structure: an annual flat fee per MAH (NOK 32,500 for 2026, up from NOK 26,500 in 2023 and NOK 31,500 in 2025) plus a sales-based fee of 0.035% of prior-year net sales (GIP) for 2026, with new entrants paying an additional one-time NOK 15,000 fee. The go-to-market is sales-led and enterprise-direct: MAHs must sign agreements to upload product data to the EU HUB, while pharmacies, wholesalers, and hospitals are onboarded directly with onboarding, baseline testing approval for software suppliers, and user provisioning. The 1-10 person organization operates with a lean team (CEO, Operations Manager, Quality Manager, and Project/Alert Manager) supported by Arvato Systems as the technical infrastructure partner.

Name

Nomvec AS

Legal name

Nomvec AS

Website

https://nomvec.no

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Nomvec AS operates Norway's national e-verification database (NoMVS) for pharmaceutical products, preventing falsified medicines from entering the supply chain under EU Regulation 2016/161. The non-profit serves Marketing Authorization Holders, pharmacies, wholesalers, and hospitals across Norway within the pan-European EMVS network.

Ownership category

akta.pro rank

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. NoMVS Fee - Flat Fee Component: Annual flat fee charged per Marketing Authorization Holder (MAH) for access to and use of the Norwegian Medicines Verification System. For 2026: NOK 32,500 per MAH.
2. NoMVS Fee - Sales-Based Component: Percentage-based fee calculated on reported actual sales (GIP) from the previous year. For 2026: 0.035% of 2025 net sales. New entrants pay a one-time new-entrant fee of NOK 15,000 in addition to annual fees.
3. New Entrant Fee: One-time fee for new Marketing Authorization Holders joining the system. For 2026: NOK 15,000 new-entrant fee plus NOK 32,500 annual flat fee (total NOK 47,500).

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Nomvec AS develops, operates, and maintains NoMVS (Norwegian Medicines Verification System), a national e-verification database for pharmaceutical products that verifies and decommissions prescription medicine packages using 2D matrix codes containing unique serial numbers, product codes, batch numbers, and expiry dates. The system connects to the EU HUB for cross-border medicine verification across 29 European countries and is mandated by EU Regulation 2016/161 (Falsified Medicines Directive) to prevent falsified medicines from reaching patients.

Product overview

Nomvec AS operates NoMVS (Norwegian Medicines Verification System), the national e-verification database for pharmaceutical products in Norway, under agreement with NoMVO. The system is part of the pan-European EMVS network connected via EU-HUB. Core functionality includes verification and decommissioning of prescription medicine packages using 2D matrix codes. Supporting modules include the Alert Management System for detecting potential falsifications, Alert Distribution service (3x weekly notifications), Troubleshooting Matrix for error resolution, MAH Onboarding for pharmaceutical company connections, SWS Connection Process for IT supplier integration, and Nordic Recall/Withdrawal recommendations. The organization also provides SPOC first-line support services.

Differentiator

Problem solved

Functional benefit

Products and services

• NoMVS (Norwegian Medicines Verification System) The Norwegian e-verification database for pharmaceutical products that enables verification and decommissioning of prescription medicine packages using 2D matrix codes. Connects to the EU-HUB for cross-border medicine verification across 29 European countries. Used by Marketing Authorization Holders, pharmacies, wholesalers, and hospitals in Norway.
• SPOC (Single Point of Contact) First-line support service for all end users in NoMVS. Handles alert distribution 3 times weekly and provides assistance with error message investigation. Service provided to pharmacies, wholesalers, hospitals, and software suppliers.

Quantifiable outcome

• 60 million medicine packages verified annually in Norway
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability4 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• Arvato SystemscoreTechnology or IntegrationSystem supplier for NoMVS (Norwegian Medicines Verification System). Arvato Systems provides the technical infrastructure for the national verification database, which connects to the EU HUB. Norway is among 16 countries using Arvato Systems as their NMVS supplier, working together in a customer group for development, operation, and maintenance.
• DifacoreTechnology or IntegrationHandles technical connection for pharmacies via EIK (pharmacy common IT system). Manages certificate and password implementation for pharmacy access to NoMVS. Also handles technical aspects of hospital department and wholesaler connections for those using EIK.
• EMVO (European Medicines Verification Organization)coreTechnology or IntegrationEMVO operates, validates, and develops the European HUB that connects all national medicines verification databases. Nomvec connects NoMVS to the EU HUB for cross-border verification of medicines.
• NoMVO (Norwegian Medicines Verification Organisation)coreStrategic or Co-development PartnerDecision-making body for implementation, management, and operation of NoMVS. NoMVO has delegated daily operations and support responsibilities to Nomvec. Board representation includes all stakeholder organizations: LMI, Farma Norge, Parallellimportørforeningen, Legemiddelgrossistforeningen, and Apotekforeningen.
• Nordic NMVO Network (DMVO, e-VIS, FiMVO, ICEMVO)coreStrategic or Co-development PartnerCollaboration among Nordic national medicines verification organizations on system stability, alert management, and joint recommendations for recall and withdrawal procedures. Published Nordic recommendations for handling batch recalls through EMVS.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• TraceLink: Commercial pharmaceutical serialisation and track-and-trace network platform used by MAHs and wholesalers to connect to NMVOs. A potential alternative integration layer for commercial pharma supply-chain stakeholders served by Nomvec.
• Optel Group: Supply-chain traceability solutions provider (serialisation, aggregation, line vision) for pharmaceutical manufacturers. Adjacent rather than directly competing with Nomvec's verification database role.

Direct peers

• securPharm e.V. Germany's national medicines verification organisation, operating securPharm as the German NMVS connected to the EU HUB. Most direct functional peer to Nomvec, executing the same FMD-mandated verification model at much larger scale.
• ICEMVO (Icelandic Medicines Verification Organisation): Iceland's NMVO, the smallest Nordic peer that collaborates with Nomvec on joint Nordic recommendations for handling batch recalls in EMVS.
• DMVO (Dansk Medicin Verifikation Organisation): Denmark's national medicines verification organisation, a direct Nordic peer collaborating with Nomvec on alert handling, recalls, and cross-border verification through the EU HUB.
• e-VIS (Swedish e-Health Agency / Swedish Medicines Verification): Sweden's medicines verification organisation, a fellow Nordic NMVO that collaborates with Nomvec on shared Nordic recall and withdrawal guidelines through EMVS.
• FiMVO (Finnish Medicines Verification Organisation): Finland's NMVO, operating the Finnish Medicines Verification System. Direct Nordic peer, jointly publishing recall guidelines with Nomvec and using the same Arvato Systems backbone in many cases.

Broad incumbents

• SAP (SAP ATTP / Pharmaceutical Track & Trace): SAP's Advanced Track & Trace for Pharmaceuticals platform serialises products and integrates with NMVOs/EU HUB. Overlaps Nomvec indirectly as a parallel serialisation infrastructure layer for global pharma manufacturers.
• EMVO (European Medicines Verification Organisation): Brussels-based organisation that operates, validates, and develops the EU HUB connecting all national medicines verification systems. Functions as the umbrella industry body above Nomvec within the EMVS governance structure.

Others

• Arvato Systems: Technology vendor providing the NoMVS platform and the SWS portal under a shared customer group with 16 NMVO countries. Not a competitor but the most operationally significant counterpart to Nomvec.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nomvec

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nomvec AS